Candel Therapeutics Competitors and Similar CompaniesClear all
Candel Therapeutics's competitors and similar companies include Nektar Therapeutics and Oncopeptides.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | |||
Founding Date | Founding Date 1999 | Founding Date 1990 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Needham, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 50 | Employees 61821% increase | Employees 80 |
Valuation ($) | Valuation ($) 176.8 m | Valuation ($) 233.8 m | Valuation ($) 42.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) kr71.1m (FY, 2025) |
Net income | Net income ($38.2m) (FY, 2025) | Net income ($164.1m) (FY, 2025) | Net income (kr249.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 64.6m | Total funding raised $ 45m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company